Publication details
Edoxaban v klinických studiích a v klinické praxi
| Title in English | Erdoxaban in clinical trials and in the clinical practise |
|---|---|
| Authors | |
| Year of publication | 2016 |
| Type | Article in Periodical |
| Magazine / Source | Remedia |
| MU Faculty or unit | |
| Citation | |
| Field | Cardiovascular diseases incl. cardiosurgery |
| Keywords | edoxaban; atrial fibrillation; venous thrombosis; lung embolism |
| Description | Edoxaban - a direct inhibitor of factor Xa - has a confirmed anticoagulant and antiagregants effect and is available in does 15, 30 and 60 mg. |